Position in RVMD
as of Sep 30, 2026
· filed Oct 8, 2026
Position Value
$93,803
+$93,429 QoQ
Shares Held
457
+22750.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 22 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Sep 30, 2026CoreCap Advisors, LLC holds $2,863,721 across 75 Biotechnology names. RVMD ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
12,114 | $707,578 | |
| 2 | MRNA |
Moderna, Inc.
|
3,324 | $640,102 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
618 | $323,096 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
249 | $188,809 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
603 | $188,359 | |
| 6 | ANIX |
Anixa Biosciences Inc
|
62,020 | $181,718 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
280 | $141,108 | |
| 8 | RVMD |
Revolution Medicines, Inc.
This page
|
457 | $93,803 |
All Filings in RVMD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-09-30 | $93,803 | 457 | Shares | Sole | 2026-10-08 | |
| 2026-06-30 | $374 | 2 | Shares | Sole | 2026-07-06 | |
| No filing history on record for this holder in this stock. | ||||||